Licy L. Yanes Cardozo, Associate Editor
Licy L. Yanes Cardozo, MD, is an Associate Professor in the Departments of Cell and Molecular Biology and Medicine/Endocrinology at the University of Mississippi Medical Center (UMMC). She received her Medical Degree at the National University of Asuncion (Paraguay) and performed the residency in Internal Medicine at the same institution. Later on, she performed postdoctoral studies studying the mechanisms by which androgens regulate blood pressure under the mentorship of Dr. Jane Reckelhoff at the Department of Physiology at UMMC. After she rose to the academic rank of Assistant Professor in Physiology, she joined the department of Medicine, where she completed the residency in Internal Medicine and fellowship in Endocrinology. Currently, she is a physician-scientist engaged in basic research and clinical research. Her research focus on the elucidation of the role and mechanism by which androgen excess mediates cardiovascular and metabolic diseases in women including polycystic ovary syndrome, anabolic steroids abuse and transgender subjects.
Rebecca L Cunningham, Associate Editor
Dr. Cunningham, PhD, is a Professor and Associate Dean for Research in the Department of Pharmaceutical Sciences at the University of North Texas Health Science Center. Throughout her scientific career, Dr. Cunningham has investigated the impact of sex on CNS function and physiology. Her research program is focused on the neurobiology of steroid sex hormones (e.g., testosterone, estradiol), neuropeptides (e.g., angiotensin), and oxidative stress mediated mechanisms and its influences on mediating sex differences in aging and neurodegenerative diseases (e.g., Alzheimer’s disease).
Joshua Rubin, Associate Editor
Joshua Rubin attended Yale University and received his MD, PhD from the Albert Einstein College of Medicine. He completed residency training in pediatrics at Boston Children’s Hospital, and a pediatric hematology-oncology fellowship at the Dana-Farber Cancer Institute and Harvard University, where he also completed post-doctoral training in Dr. Rosalind’s Segal laboratory. He joined the faculty at the Washington University School of Medicine in 2003 where he is now a Professor of Pediatrics and Neuroscience. He founded and co-led the Pediatric Neuro-Oncology Program at St. Louis Children’s Hospital until 2020. He currently is a Co-Leader of the Solid Tumor Therapeutics Program at The Siteman Cancer at Washington University School of Medicine. In his laboratory, he has focused on the biology of sex differences in cancer and their implications for treatment for a number of years. Specific lines of investigation include sex differences in metabolism, epigenetics, stem cell function, and responses to DNA damage. The long-term goals for his laboratory are a deeper understanding of cancer in males versus females, and how best to incorporate this knowledge to improve outcomes for all patients.